The Reserve Bank of India is expected to increase interest rates soon. This move aligns with other central banks responding to rising infla...

India's fourth-largest company, Rajesh Exports, faces a Sebi probe for alleged financial fraud. Investigations point to accounting irregula...

Regulator Sebi has issued an interim order against Rajesh Exports and its promoter, Rajesh Mehta. The company faces allegations of signific...

Foreign companies are exiting India for various reasons, from business failures to global strategy shifts. India aims to build national cha...

The finance industry is rapidly adopting AI, but soaring costs for computing power and AI assistants like Claude are creating financial str...

If the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...

The ride-hailing giant this week disclosed it had boosted its stake in Frankfurt-listed Delivery Hero. It’s working with advisers to study ...

In a bid to bolster reserves, central banks are poised to increase their gold purchases, potentially reviving gold prices as we approach th...

Union Home Minister Amit Shah celebrated BJP's victories in West Bengal and Gujarat local body polls. He stated the BJP and its allies now ...

Bulls argue this company is becoming a complete mobility-platform supplier in India: Power solutions and aftermarket, braking and safety. B...

Travellers face more flight cancellations as airlines grapple with sky-high jet fuel costs. Carriers globally are reducing flights and park...

A distant war is impacting global luxury sales. Europe's top luxury firms have lost billions in market value. The Middle East, a key growth...

MCX has delivered over 150% returns in a year, far outperforming global exchange operators, as structural reforms, rising derivatives volum...

Eisai Co, a Tokyo-based pharmaceutical company with a family bent and market capitalisation of $14 billion, crossed the finish line before ...

"Private market investors have to pay aggressive multiples to access India's growth potential. Yes, it's a high price, but per unit of grow...

While this probably won’t help people who are born deaf, scientists are hopeful it will work for patients who lost their hearing at a young...

A takeover of Illumina would be Roche’s largest purchase since the $46.8 billion acquisition of Genentech Inc., completed in March 2009.